Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSE:AUP)'s stock price reached a new 52-week high during mid-day trading on Monday after HC Wainwright raised their price target on the stock from $30.00 to $35.00. HC Wainwright currently has a buy rating on the stock. Aurinia Pharmaceuticals traded as high as $23.80 and last traded at $20.60, with a volume of 387735 shares trading hands.
https://www.marketbeat.com/instant-alerts/nasdaq-auph-price-alert-2021-01/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.